Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Stage I-II Breast Cancer Who Have Undergone Surgery
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Stage IA Breast Cancer|Stage IB Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer
Interventions: DRUG: cyclophosphamide|DRUG: paclitaxel|BIOLOGICAL: trastuzumab|OTHER: laboratory biomarker analysis
Sponsor: University of Nebraska
Collaborators: National Cancer Institute (NCI)